Mr. Thomas Hoover is a skilled commercial strategist with over 20 years of experience in the pharmaceutical industry across many therapeutic areas. As Chief Business Officer, Mr. Hoover leads Millendo’s strategic business development and planning efforts. Previously, he led Millendo’s marketing, sales, patient engagement and managed markets functions as the company’s Chief Commercial Officer. Prior to joining Millendo, Mr. Hoover served as vice president of new products planning and corporate development at Sunovion Pharmaceuticals (formerly Sepracor), where he held responsibilities for product strategy, portfolio management and business development. Prior to Sunovion, Mr. Hoover was a senior director in the global commercial strategy group at GlaxoSmithKline, where he provided commercial input into R&D decision making. Before starting his pharmaceutical career, Mr. Hoover spent 4 years at The Boston Consulting Group.
Mr. Hoover holds a B.A. in economics from Harvard College and an M.B.A. from the Kenan-Flagler Business School at the University of North Carolina at Chapel Hill.